Chemo-Immunotherapeutic Antimalarials Targeting Isoprenoid Biosynthesis - Wikidata - awgldk - TriplyDB

Chemo-Immunotherapeutic Antimalarials Targeting Isoprenoid Biosynthesis

Chemo-Immunotherapeutic Antimalarials Targeting Isoprenoid Biosynthesis

http://www.wikidata.org/entity/Q27677518

about

Structure of human farnesyl pyrophosphate synthase in complex with an aminopyridine bisphosphonate and two molecules of inorganic phosphate Squalene synthase as a target for Chagas disease therapeutics Taxodione and arenarone inhibit farnesyl diphosphate synthase by binding to the isopentenyl diphosphate site Anti-Tumor Activity and Immunotherapeutic Potential of a Bisphosphonate Prodrug.A combination therapy for KRAS-driven lung adenocarcinomas using lipophilic bisphosphonates and rapamycin In Vitro and In Vivo Investigation of the Inhibition of Trypanosoma brucei Cell Growth by Lipophilic Bisphosphonates.Enhancing adoptive cancer immunotherapy with Vγ2Vδ2 T cells through pulse zoledronate stimulation Targeting Cancer Cells with a Bisphosphonate Prodrug.Geranyl and neryl triazole bisphosphonates as inhibitors of geranylgeranyl diphosphate synthase.Solvent effect on molecular structure, IR spectra, thermodynamic properties and chemical stability of zoledronic acid: DFT study.Structure, Function, and Inhibition of Staphylococcus aureus Heptaprenyl Diphosphate Synthase.Molecular mechanisms linking geranylgeranyl diphosphate synthase to cell survival and proliferation.Phosphonic acid: preparation and applications.Specific Inhibition of the Bifunctional Farnesyl/Geranylgeranyl Diphosphate Synthase in Malaria Parasites via a New Small-Molecule Binding Site.

P2860

Q27682018-E707248E-0E6B-4C42-BAAE-56DFBB530B53 Q27683611-0D4EC068-3036-4254-AF92-5D51A3A131F2 Q27684323-EB0AF252-0DF8-4141-BAB0-6E563695C0E6 Q33920919-34748AC8-7ACC-4CB9-878E-531E5608849B Q35078290-D07DC6BC-18DF-4B09-85D2-179D7D0C027B Q35782846-571DB808-6581-4A73-A054-ED6B95FA0669 Q37655345-618C57D8-14BE-442C-AECD-D9B6DDBC0E91 Q38736342-582060ED-F163-476D-B3B4-88C0B9A8081B Q39004999-EC16858A-02D0-4BCC-B317-B88F7D9C42D2 Q39905819-4800781A-76D1-446F-8B5E-2E723A7778B7 Q41025749-1B03EF1F-BB34-4A18-851A-56A1BB24FC41 Q41162635-BBF72EE8-9CE2-4D14-904B-2E0F0CD45613 Q47165356-85184B74-549B-460D-9055-D4B21791F020 Q48020178-E312AE0A-D94B-4174-88A8-89B66C42EDCE

P2860

Chemo-Immunotherapeutic Antimalarials Targeting Isoprenoid Biosynthesis

http://www.wikidata.org/entity/Q27677518

description

2013 nî lūn-bûn

@nan

2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Chemo-Immunotherapeutic Antimalarials Targeting Isoprenoid Biosynthesis

@ast

Chemo-Immunotherapeutic Antimalarials Targeting Isoprenoid Biosynthesis

@en

Chemo-Immunotherapeutic Antimalarials Targeting Isoprenoid Biosynthesis

@nl

type

label

Chemo-Immunotherapeutic Antimalarials Targeting Isoprenoid Biosynthesis

@ast

Chemo-Immunotherapeutic Antimalarials Targeting Isoprenoid Biosynthesis

@en

Chemo-Immunotherapeutic Antimalarials Targeting Isoprenoid Biosynthesis

@nl

prefLabel

Chemo-Immunotherapeutic Antimalarials Targeting Isoprenoid Biosynthesis

@ast

Chemo-Immunotherapeutic Antimalarials Targeting Isoprenoid Biosynthesis

@en

Chemo-Immunotherapeutic Antimalarials Targeting Isoprenoid Biosynthesis

@nl

P1433

Q27677518-3F40936F-D2D2-480D-874C-4326C0867814

P1476

Q27677518-65222AAB-DDEA-4F13-8527-7F8C9D48F3FC

P2093

Q27677518-0EC33DD1-7A6B-4784-8B7B-DC3AB8D3F587

Q27677518-153CBDB2-6ECA-4D4E-89FF-EFF50C987CAF

Q27677518-2904FCD6-E223-4548-8231-047042D2B4DB

Q27677518-29A94125-240B-4FE5-AE09-F8F3AC3FC114

Q27677518-401231BA-8DB9-4CF3-A300-95909103576B

Q27677518-84F0A9B8-CEB3-444E-8574-04187E8F1C6D

Q27677518-871133D3-26FF-427E-9D82-615631840686

Q27677518-8DA3E924-10A8-4623-9E51-2E8273F4C42C

Q27677518-92153BEC-63C1-423D-A9E4-7004516DAB1A

Q27677518-93BB76D7-4795-434B-9CD8-1A90178715CB

P2860

Q27677518-0F1B5C48-00A4-43A4-BA51-CCFC1D0CDE02

Q27677518-16C2615C-2E51-4821-96CB-62995E857837

Q27677518-2A491006-0365-46C5-9C0D-AE1E62173479

Q27677518-2A536047-90EC-434F-944D-E693B65A67B9

Q27677518-383D4104-A87E-46F1-8B99-60D6E8DEDF35

Q27677518-403A6002-3D62-44B9-86F3-CB83BA3798CF

Q27677518-5AB03D4C-6295-4153-A688-438331AE97DE

Q27677518-5C583E72-E959-431C-BB11-BA4CD73D807A

Q27677518-5E862F84-F251-4DC0-AC6C-E1B69E9B5E41

Q27677518-66DD47B9-DAF2-44CE-A9C4-EE5E262F1550

P304

Q27677518-895324C2-0207-476E-AEEB-FBF75FFDC72A

P31

Q27677518-A14EC0EB-6F44-4125-A959-CEE3D8E053B8

P356

Q27677518-FD480CFA-19AC-4E1B-8644-5C6419135B25

P433

Q27677518-C13CCD7E-E8C9-48E6-AF8A-EC9B08257205

P478

Q27677518-97874EDF-C53E-48D8-899D-800E55FE84CD

P50

Q27677518-434567CB-8F09-4403-B16E-D3564CF476B1

P577

Q27677518-F2BD0CFE-6A8B-4C67-8834-91EF23056C52

P698

Q27677518-47AE5F5B-DA2D-4546-9AF3-F172ADFB3B8E

P921

Q27677518-07CF9090-CD21-4164-A568-418EA912E1F7

Q27677518-43D5BDA5-2B65-4529-998A-B07DC78E3856

Q27677518-69000653-BCEB-4597-8BDB-D90B626AA2E1

Q27677518-98ECEDCB-5832-43F0-BBA1-0697D72FFB03

P932

Q27677518-9D5EC963-666C-4F47-85EB-EC847C9D53B1

P356

P1433

ACS Medicinal Chemistry Letters

P1476

Chemo-Immunotherapeutic Antimalarials Targeting Isoprenoid Biosynthesis

@en

P2093

Anmol Gulati

http://www.w3.org/2001/XMLSchema#string

Craig T Morita

http://www.w3.org/2001/XMLSchema#string

Eric Old-Field

http://www.w3.org/2001/XMLSchema#string

Hong Wang

http://www.w3.org/2001/XMLSchema#string

Joo Hwan No

http://www.w3.org/2001/XMLSchema#string

Kai Li

http://www.w3.org/2001/XMLSchema#string

Ke Wang

http://www.w3.org/2001/XMLSchema#string

Lawrence Ayong

http://www.w3.org/2001/XMLSchema#string

Ran Pang

http://www.w3.org/2001/XMLSchema#string

Wei Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

Lipophilic Bisphosphonates as Dual Farnesyl/Geranylgeranyl Diphosphate Synthase Inhibitors: An X-ray and NMR Investigation

Lipophilic analogs of zoledronate and risedronate inhibit Plasmodium geranylgeranyl diphosphate synthase (GGPPS) and exhibit potent antimalarial activity

Regulation of product chain length by isoprenyl diphosphate synthases

Antibacterial effect of human V gamma 2V delta 2 T cells in vivo

Inhibitory effect of TNF-α on malaria pre-erythrocytic stage development: influence of host hepatocyte/parasite combinations

Carotenoid biosynthesis in intraerythrocytic stages of Plasmodium falciparum

Plasmodium falciparum-infected erythrocytes induce granzyme B by NK cells through expression of host-Hsp70.

Bisphosphonate inhibition of a Plasmodium farnesyl diphosphate synthase and a general method for predicting cell-based activity from enzyme data

Lipophilic bisphosphonates are potent inhibitors of Plasmodium liver-stage growth.

The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs.

P304

423-427

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ML4000436

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Lucio Freitas-Junior

P577

2013-04-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23610597

http://www.w3.org/2001/XMLSchema#string

P921

Aagianik kimischri

P932

3630516

http://www.w3.org/2001/XMLSchema#string